Dr. Doreen Matsui, MD, FRCPC
Children’s Health Research Institute
Scientist, Children’s Optimal Therapeutics Program
Lawson Health Research Institute
Scientist, Children’s Health Research Institute
Children’s Hospital of Western Ontario
Consultant, Clinical Pharmacology
University of Western Ontario
Associate Professor, Departments of Paediatrics and Medicine
Contact Information
Tel: (519) 685-8500 Ext. 58268
Fax: (519) 685-8156
E-mail: Doreen.matsui@lhsc.on.ca
Brief Biography
Dr. Doreen Matsui received her Degree in Medicine from Queen’s University in 1985. She completed a residency in paediatrics at the Children’s Hospital of Eastern Ontario, University of Ottawa and a fellowship in paediatric clinical pharmacology at the Hospital for Sick Children, University of Toronto. She also received a Certificate in Clinical Epidemiology from The University of Western Ontario in 2002.
Dr. Matsui joined the Schulich School of Medicine at The University of Western Ontario in 1993, and is a paediatrician and clinical pharmacologist at the Children’s Hospital of Western Ontario. She is an Associate Professor in the Departments of Paediatrics and Medicine. She currently is a member of the Review Board for Health Sciences Research Involving Human Subjects at The University of Western Ontario and Chair of the Drug Therapy and Hazardous Substances Committee of the Canadian Paediatric Society.
Research Interests
• Drug therapy in children, medication compliance and the effects of drugs in pregnancy
Research Activities
Dr. Matsui’s research interests include drug therapy in children, medication compliance and the effects of drugs in pregnancy. She was awarded the K.M Piafsky Young Investigator Award of the Canadian Society for Clinical Pharmacology in 1998.
Awards and Recognition
Funding in support of "Correlation of clinical symptoms with serum levels and CYP2D6 status in newborns who were exposed to paroxetine in utero" (co-investigator)
Awarded by Children’s Optimal Therapeutics Program
Funding in support of "Rural Women and Pharmaceutical Use: Issues, Challenges and Solutions". Awarded by Lawson Health Sciences Research Institute
Funding in support of "Establishing Canadian Network for Natural Health Products in Pregnancy and Lactation" (co-investigator) Awarded by Health Canada - NHP Research Program
Funding in support of "Genotype-specific Approaches to Therapy in Childhood (GATC) to study adverse drug reactions in children" in collaboration with the University of British Columbia. Awarded by Genome Canada
Click here to see Publications
